FDA: PPIs and Clostridium Difficile

Published Online: Friday, July 20, 2012
In this podcast, Steve Jackson, a pharmacist in the FDA’s division of drug information, warns that use of proton pump inhibitors (PPIs) may be associated with an increased risk of Clostridium difficile–associated diarrhea.
 
To listen to the podcast, click here.
Related Articles
Recent study on healing rates of reflux esophagitis patients suggests that some refractory patients may heal with extended acid suppression treatment.
Since the introduction of routine rotavirus vaccination in 2006, rates of diarrhea-related hospitalizations in US children have decreased significantly.
A recent study indicates that eating meals quickly does not increase reflux episodes in gastroesophageal reflux disease patients.
Latest Issues
$auto_registration$